• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2:受体和共受体嗜性概率。

SARS-CoV-2: Receptor and Co-receptor Tropism Probability.

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, 5166/15731, Tabriz, Iran.

出版信息

Curr Microbiol. 2022 Mar 16;79(5):133. doi: 10.1007/s00284-022-02807-7.

DOI:10.1007/s00284-022-02807-7
PMID:35292865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8923825/
Abstract

The recent pandemic which arose from China, is caused by a pathogenic virus named "severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2)". Its rapid global expansion has inflicted an extreme public health concern. The attachment of receptor-binding domains (RBD) of the spike proteins (S) to the host cell's membrane, with or without the help of other cellular components such as proteases and especially co-receptors, is required for the first stage of its pathogenesis. In addition to humans, angiotensin-converting enzyme 2 (ACE2) is found on a wide range of vertebrate host's cellular surface. SARS-CoV-2 has a broad spectrum of tropism; thus, it can infect a vast range of tissues, organs, and hosts; even though the surface amino acids of the spike protein conflict in the receptor-binding region. Due to the heterogeneous ACE2 distribution and the presence of different domains on the SARS-CoV-2 spike protein for binding, the virus entry into diverse host cell types may depend on the host cells' receptor presentation with or without co-receptors. This review investigates multiple current types of receptor and co-receptor tropisms, with other molecular factors alongside their respective mechanisms, which facilitate the binding and entry of SARS-CoV-2 into the cells, extending the severity of the coronavirus disease 2019 (COVID-19). Understanding the pathogenesis of COVID-19 from this perspective can effectively help prevent this disease and provide more potent treatment strategies, particularly in vulnerable people with various cellular-level susceptibilities.

摘要

近期源自中国的疫情是由一种名为“严重急性呼吸系统综合征相关冠状病毒-2(SARS-CoV-2)”的致病病毒引起的。它在全球范围内的迅速传播引发了人们对公共卫生的极大关注。病毒的刺突蛋白(S)的受体结合域(RBD)与宿主细胞膜结合,无论是否有其他细胞成分(如蛋白酶和特别的共受体)的协助,这是其发病机制的第一阶段所必需的。除了人类,血管紧张素转换酶 2(ACE2)也存在于多种脊椎动物宿主的细胞表面。SARS-CoV-2 具有广泛的嗜性;因此,它可以感染广泛的组织、器官和宿主;尽管刺突蛋白的表面氨基酸在受体结合区域存在冲突。由于 ACE2 的分布不均和 SARS-CoV-2 刺突蛋白上用于结合的不同结构域,病毒进入不同宿主细胞类型的方式可能取决于宿主细胞是否存在共受体来呈现受体。本综述探讨了多种当前类型的受体和共受体嗜性,以及其他分子因素及其各自的机制,这些因素促进了 SARS-CoV-2 进入细胞,从而加重了 2019 年冠状病毒病(COVID-19)的病情。从这个角度理解 COVID-19 的发病机制可以有效地帮助预防这种疾病,并提供更有效的治疗策略,特别是针对具有各种细胞水平易感性的易感染人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411c/8923825/dc35fe2330d1/284_2022_2807_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411c/8923825/1d4ea475aefc/284_2022_2807_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411c/8923825/79bb598b4e31/284_2022_2807_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411c/8923825/dc35fe2330d1/284_2022_2807_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411c/8923825/1d4ea475aefc/284_2022_2807_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411c/8923825/79bb598b4e31/284_2022_2807_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/411c/8923825/dc35fe2330d1/284_2022_2807_Fig3_HTML.jpg

相似文献

1
SARS-CoV-2: Receptor and Co-receptor Tropism Probability.SARS-CoV-2:受体和共受体嗜性概率。
Curr Microbiol. 2022 Mar 16;79(5):133. doi: 10.1007/s00284-022-02807-7.
2
Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.高度保守的 ACE2 结合区域作为人类和哺乳动物之间 SARS-CoV-2 的受体。
Vet Q. 2020 Dec;40(1):243-249. doi: 10.1080/01652176.2020.1823522.
3
SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.SARS-CoV-2 宿主嗜性:主要细胞因子的计算分析。
Virus Res. 2020 Nov;289:198154. doi: 10.1016/j.virusres.2020.198154. Epub 2020 Sep 9.
4
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.COVID-19 大流行:对 SARS-CoV-2 结构、功能和 hACE2 受体识别的深入了解。
PLoS Pathog. 2020 Aug 21;16(8):e1008762. doi: 10.1371/journal.ppat.1008762. eCollection 2020 Aug.
5
Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.新冠病毒刺突蛋白与人血管紧张素转化酶 2 协同结合和信号转导的共进化、动力学和变构协同作用。
Int J Mol Sci. 2020 Nov 4;21(21):8268. doi: 10.3390/ijms21218268.
6
Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.基于 SARS-CoV-2 刺突蛋白/血管紧张素转化酶 2 复合物的丙氨酸扫描计算和结构分析。
ACS Nano. 2020 Sep 22;14(9):11821-11830. doi: 10.1021/acsnano.0c04674. Epub 2020 Aug 26.
7
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.新冠病毒 2 型受体(SARS-CoV-2 receptor),血管紧张素转换酶 2 基因(angiotensin-converting enzyme 2 gene)在 COVID-19 中的表达和意义。
Mol Biol Rep. 2020 Jun;47(6):4383-4392. doi: 10.1007/s11033-020-05478-4. Epub 2020 May 14.
8
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.SARS-CoV-2 策略性地模拟人类 ENaC 的蛋白水解激活。
Elife. 2020 May 26;9:e58603. doi: 10.7554/eLife.58603.
9
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.SARS-CoV-2 刺突蛋白在细胞进入中的动力学:氨基末端结构域中的控制元件。
mBio. 2021 Aug 31;12(4):e0159021. doi: 10.1128/mBio.01590-21. Epub 2021 Aug 3.
10
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.SARS-CoV-2 与 ACE2 受体结合的分子相互作用和抑制。
Nat Commun. 2020 Sep 11;11(1):4541. doi: 10.1038/s41467-020-18319-6.

引用本文的文献

1
Ferroptosis and non-coding RNAs in breast cancer: insights into CAF and TAM interactions.乳腺癌中的铁死亡与非编码RNA:对癌症相关成纤维细胞和肿瘤相关巨噬细胞相互作用的见解
Discov Oncol. 2025 Aug 31;16(1):1658. doi: 10.1007/s12672-025-03507-x.
2
SARS-CoV-2 spike treatment and transfection impairs airway epithelial repair.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白处理和转染会损害气道上皮修复。
ERJ Open Res. 2025 Aug 4;11(4). doi: 10.1183/23120541.00940-2024. eCollection 2025 Jul.
3
Targeting Metastasis: Exploring the Impact of Microbial Infections on Cancer Progression Through Innovative Biological Models.

本文引用的文献

1
Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion.细胞外波形蛋白作为抗 SARS-CoV-2 宿主细胞入侵的靶点。
Small. 2022 Feb;18(6):e2105640. doi: 10.1002/smll.202105640. Epub 2021 Dec 5.
2
Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.关注的 SARS-CoV-2 变体的人类 ACE2 和 Spike RBD 之间的差异相互作用。
J Chem Theory Comput. 2021 Dec 14;17(12):7972-7979. doi: 10.1021/acs.jctc.1c00965. Epub 2021 Dec 3.
3
Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2.
靶向转移:通过创新生物学模型探索微生物感染对癌症进展的影响
Curr Microbiol. 2025 Jun 7;82(7):328. doi: 10.1007/s00284-025-04306-x.
4
Exosomal non-coding RNAs: gatekeepers of inflammation in autoimmune disease.外泌体非编码RNA:自身免疫性疾病炎症的守门人。
J Inflamm (Lond). 2025 May 14;22(1):18. doi: 10.1186/s12950-025-00443-z.
5
Jamaican fruit bat (Artibeus jamaicensis) insusceptibility to mucosal inoculation with SARS-CoV-2 Delta variant is not caused by receptor compatibility.牙买加果蝠(Artibeus jamaicensis)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变种黏膜接种不敏感并非由受体兼容性所致。
Npj Viruses. 2024 Jul 16;2(1):26. doi: 10.1038/s44298-024-00037-1.
6
The ACE2 Receptor from Common Vampire Bat () and Pallid Bat () Support Attachment and Limited Infection of SARS-CoV-2 Viruses in Cell Culture.普通吸血蝠()和苍白洞蝠()的ACE2受体在细胞培养中支持SARS-CoV-2病毒的附着和有限感染。
Viruses. 2025 Mar 31;17(4):507. doi: 10.3390/v17040507.
7
Structural Virology: The Key Determinants in Development of Antiviral Therapeutics.结构病毒学:抗病毒治疗药物研发中的关键决定因素
Viruses. 2025 Mar 14;17(3):417. doi: 10.3390/v17030417.
8
Variant-Specific Interactions at the Plasma Membrane: Heparan Sulfate's Impact on SARS-CoV-2 Binding Kinetics.质膜上的变体特异性相互作用:硫酸乙酰肝素对SARS-CoV-2结合动力学的影响。
Anal Chem. 2025 Mar 4;97(8):4318-4328. doi: 10.1021/acs.analchem.4c04283. Epub 2025 Feb 20.
9
Pharmacoinformatics-based screening and construction of a neutralizing anti-SARS-CoV-2 camelidae nanobody drug conjugate.基于药物信息学的中和抗SARS-CoV-2骆驼科纳米抗体药物偶联物的筛选与构建
Mol Divers. 2025 Jan 28. doi: 10.1007/s11030-024-11086-2.
10
Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy.利用二维和三维人类子宫内膜细胞培养模型研究妊娠早期的新冠病毒感染
Clin Sci (Lond). 2025 Feb 19;139(4):CS20241215. doi: 10.1042/CS20241215.
含唾液酸的糖脂介导 SARS-CoV-2 的结合和病毒进入。
Nat Chem Biol. 2022 Jan;18(1):81-90. doi: 10.1038/s41589-021-00924-1. Epub 2021 Nov 9.
4
Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis.伊维菌素治疗 COVID-19 的疗效和安全性:系统评价和荟萃分析。
QJM. 2021 Dec 20;114(10):721-732. doi: 10.1093/qjmed/hcab247.
5
Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain.细胞外波形蛋白在癌细胞功能中的作用及其对 SARS-CoV-2 受体结合域诱导的细胞单层通透性变化的影响。
Int J Mol Sci. 2021 Jul 12;22(14):7469. doi: 10.3390/ijms22147469.
6
L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus.L-SIGN 是肝脏窦状内皮细胞上的 SARS-CoV-2 病毒受体。
JCI Insight. 2021 Jul 22;6(14):e148999. doi: 10.1172/jci.insight.148999.
7
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.硫酸乙酰肝素蛋白聚糖作为新冠病毒的附着因子
ACS Cent Sci. 2021 Jun 23;7(6):1009-1018. doi: 10.1021/acscentsci.1c00010. Epub 2021 Jun 2.
8
Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱导的上皮-间质转化需要Snail的转录上调。
Am J Cancer Res. 2021 May 15;11(5):2278-2290. eCollection 2021.
9
Viral coinfections in COVID-19.新冠病毒的合并感染。
J Med Virol. 2021 Sep;93(9):5310-5322. doi: 10.1002/jmv.27102. Epub 2021 Jun 12.
10
Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants.实验证据表明,快速传播的 SARS-CoV-2 变异株增强了受体结合能力。
J Mol Biol. 2021 Jul 23;433(15):167058. doi: 10.1016/j.jmb.2021.167058. Epub 2021 May 21.